Thus, in this study we examined the effects of specifically modulating both cannabinoid receptors CB1 and CB2 on cell motility, cell morphology, actin cytoskeleton, p44/42 MAPK and FAK phosphorylation in glioblastoma cells. The gene discussed is CNR1; the disease is glioblastoma.